Name of the Presenter Title Reg No Date of Submission
Dr.Shikha Garg RELIABLE MINIMAL RESIDUAL DISEASE ESTIMATION IN MULTIPLE MYELOMA IS INFLUENCED BY PRESENCE OF ADEQUATE NUMBERS OF NORMAL BONE MARROW ELEMENTS TCS201830020 7/29/18 12:58
Dr.Yang Zeng Single Platform CD34+/CD45+ Cell Analysis on the BD FACSLyric™ System Using UK NEQAS Samples TCS2018USA10 8/22/18 4:16
Dr.Yang Zeng Immunophenotyping of UK NEQAS CLL Samples on the BD FACSLyric and BD FACSCanto II TCS2018USA10 8/22/18 4:16
Sandeep Kumar Vishwakarma REALTIME CELLULAR AND MOLECULAR DYNAMICS OF BI-METALLIC SELFTHERAPEUTIC NANOPARTICLE IN CANCER CELLS TCS201890488 8/23/18 15:15
Dr.Neha Singh T-ALL minimal residual disease using sequential gating strategy: experience form a tertiary care center in North India TCS201820134 8/24/18 18:27
Anita Tahlan TO ASSESS THE CORRELATION OF RAI STAGING WITH EXPRESSION OF CD38 AND ZAP 70 IN CLL PATIENTS TCS201884576 9/10/18 11:17
Monika Gupta Role of neutrophilic CD64 in early and late phase of sepsis in adults (BASIC) TCS201831102 9/10/18 18:44
GARIMA PATHAK A HAIRY CELL LEUKEMIA : A DIAGNOSTIC DILEMMA TCS201881589 9/11/18 18:23
Pratyusha Gudapati INVESTIGATING CD304-EXPRESSION IN B-Cell Precursor Acute Lymphoblastic Leukemia (BCPALL) AND ITS UTILITY IN THE BCPALL MINIMAL RESIDUAL DISEASE TESTING. TCS201849046 9/11/18 21:00
JUSTIN JACOB ADIPONECTIN AND CD161: POTENTIAL NEW PLAYERS IN CHARACTERISING EARLY AND ADVANCED KNEE OSTEOARTHRITIS TCS201874162 9/12/18 12:23
vinit sharma A PRELIMINARY STUDY TO ESTABLISH THE TYPE OF MYELOID DERIVED SUPPRESSOR CELLS AND EXTENT OF IMMUNE SUPPRESSION IN PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA TCS201852889 9/12/18 12:25
DR KIRAN AGARWAL UTILITY OF UTILITY OF FLOW CYTOMETRY IN DIAGNOSIS AND TYPING OF LYMPHOMA IN PLEURAL FLUID TCS201842185 9/12/18 13:02
Rahul Arora Flow cytometric osmotic fragility test and eosin-5’-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis TCS201875249 9/12/18 13:14
SAMBHU NATH BANERJEE Minimal Residual Disease Monitoring By 8-Color Flow Cytometry in T-ALL: An approach from a tertiary care center TCS201819606 9/12/18 17:04
AMIT KUMAR SINGH DELINEATION OF HOMEOSTATIC IMMUNE SIGNATURES DEFINING VIREMIC NON-PROGRESSION IN HIV1 INFECTION TCS201881017 9/13/18 12:21
SHASHI BANSAL CD25 EXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA-AN INDIAN PERSPECTIVE TCS201865243 9/13/18 13:37
Dr.Prabin Kumar PARASITIC LOAD IN BONE MARROW NEGATIVELY IMPACTS T CELL SUPPRESSION IN VISCERAL LEISHMANIASIS PATIENTS TCS201818180 9/13/18 16:47
Pallavi Tiwari RELEASE OF PRO & ANTI-INFLAMMATORY CYTOKINES AND DEVELOPMENT OF SIRS WITH DIFFERENT ANESTHETIC TECHNIQUES IN MAJOR ORTHOPEDIC TRAUMA SURGERIES. TCS201849461 9/13/18 17:10
Dr. Neena Mampilly Tdt negative B lymphoblastic leukemia in adults and its differentiation from High grade B cell lymphoma by flow cytometry immunophenotyping: A report of 4 cases TCS201832368 9/13/18 18:13
Smita Singh UTILITY OF CD123 EXPRESSION OVER CD58 IN MINIMAL RESIDUAL DISEASE DETECTION IN A CASE OF PEDIATRIC B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TCS201848599 9/14/18 10:34
Mr. ANIRUDDHA BAGCHI EFFECT OF Piper betle EXTRACT UPON TRANSDIFFERENTIATION OF NEUTROPHILS INTO NEUTROPHIL-DC HYBRIDS IN PATIENTS WITH RHEUMATOID ARTHRITIS TCS201894498 9/14/18 11:43
Manjiri Makde UTILITY OF FLOWCYTOMETRY IN THE DIAGNOSIS OF EXTRAMEDULLARY LYMPHOBLASTIC LYMPHOMA (LBL) ON FINE NEEDLE ASPIRATE (FNA) SAMPLES: A DIAGNOSTIC CHALLENGE TCS201885173 9/14/18 15:57
Avinash Bardia FeGdO3 bimetallic nanoparticles-blood interaction: Implication for the development of Magnetic resonance imaging based functional imaging TCS201822779 9/14/18 16:21
SHILPA BHOWMICK FLOW CYTOMETRIC EVALUATION OF ANDERSON PROMOTERS IN VIVO: QUANTITATIVE AND QUALITATIVE INSIGHTS FROM AN iGEM 2018 INTERLAB STUDY TCS201811982 9/15/18 10:22
SUKESHANI SALWE Immune Monitoring of T- Cell Function In HIV-1, HIV-2 and Dually Infected Individuals: Correlates of Disease Progression and Immune Restoration TCS201871248 9/15/18 10:34
Sundar Popat Shewale ACUTE MYELOID LEUKEMIA WITH RAM IMMUNOPHENOTYPE: 2 CASES WITH DISTINCT RECURRENT IMMUNOPHENOTYPE IDENTIFYING HIGH RISK AML TCS201857835 9/15/18 16:42
Dr. Sabina Langer HEMATOGONE HYPERPLASIA MASKING THE UNDERLYING DIAGNOSIS TCS201841507 9/15/18 17:25
Dr. Atul Tiwari ACUTE MYELOID LEUKEMIA IN A PATIENT WITH PITUITARY APOPLEXY TCS201855823 9/15/18 19:14
Sindhura Lakshmi Koulmane Laxminarayana CORRELATION OF ABERRANT ANTIGEN EXPRESSION IN ACUTE MYELOID LEUKEMIA WITH MORPHOLOGIC FAB CLASSIFICATION AND CYTOGENETIC ABNORMALITIES TCS201883634 9/15/18 19:21
Dr Nitin Sharma Development of novel organ preservation system via a rational approach TCS201840607 9/15/18 22:17
Dr.Swati Kalantri FLOW CYTOMETER DID MAKE A DIFFERENCE TO PATIENT CARE: OUR EXPERIENCE AT TERTIARY HEALTH CENTRE TCS201893364 9/20/18 22:17
SANDEEP RAI Expression Levels of CD45 in Normal Lymphocytes in Different Leukemic States TCS2018COM10 9/21/18 17:45
Tapasyapreeti Mukhopadhyay FLOWCYTOMETRIC ANALYSIS OF PLATELET FUNCTION IN TRAUMA PATIENTS WITH THROMBOCYTOPENIA TCS201843650 9/22/18 12:40
Ms.TWINKLE VIKRAM SINGH KHANKA Standardization of a two-tube 13-color (15-antibodies) flow cytometric assay for the evaluation of detailed immune cell profiling (Sixty-two immune-cell subsets) in human peripheral blood TCS201827372 9/24/18 18:22
Dr. Nupur Das LEUKEMIC STEM CELLS IN ACUTE MYELOID LEUKEMIA – IMPORTANT PREDICTOR OF MINIMAL RESIDUAL DISEASE TCS201870129 9/26/18 11:39
PANKHURI NARULA MITOCHONDRIAL TRANSIT PEPTIDE EXHIBITS CELL PENETRATION ABILITY AND EFFICIENTLY DELIVERS MACROMOLECULES TO MITOCHONDRIA TCS201869981 9/27/18 13:05
GUNIT NONGTHOMBAM THE RECEPTOR TYROSINE KINASE-LIKE ORPHAN RECEPTOR 1 (ROR1) IS A HIGHLY DISCRIMINATIVE MARKER FOR CLL DIAGNOSIS TCS201827879 9/28/18 22:02
Chandan Kumar EARLY T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE TCS201858128 9/29/18 11:16
Garima Jain EXTRAMEDULLARY RELAPSE IN CASE OF ETP-ALL IN THE FORM OF LEUKEMIA CUTIS :A RARE PRESENTATION TCS201874323 9/29/18 11:22
AVINASH GUPTA FLOW CYTOMETRIC EVALUATION OF CRLF2 OVEREXPRESSION FOR THE DIAGNOSIS OF PH-LIKE BALL IN PATIENTS FROM INDIA AND ITS ASSOCIATION WITH POST-INDUCTION MRD STATUS TCS201832055 9/29/18 21:53
RAHUL SHUKLA ROLE OF CD49D (VLA-4) IN FLOW CYTOMETRIC IMMUNOPHENOTYPING OF PLASMA CELL NEOPLASMS TCS201863121 9/30/18 12:45
Dr. GEETA YADAV LINEAGE INFIDELITY IN ACUTE UNDIFFERENTIATED LEUKEMIA- DIFFICULTIES IN DIAGNOSIS TCS201840317 9/30/18 15:05
Parvind Singh IMMUNOLOGICAL WORKUP IN SOLID ORGAN TRANSPLANTATION; A COST EFFECTIVE ALGORITHM WITH A VALUE ADDITION ON CURRENT QUALITY SCENARIOS TCS201880650 9/30/18 17:30
Subhendu Chakrabarty Microtubule targeting Tea Polyphenols induce Autophagic Cell Death in Mammalian Cancer Cells by Modulating PI3K-Akt-mTOR Axis TCS201814278 9/30/18 19:05
Khushbu khetan Acute myeloid leukaemia with “RAM” phenotype: a newly defined high-risk subtype – a report of three cases TCS201889193 9/30/18 19:14
Dr.Amlan Das Pharmacological inhibition of Notch-activating enzyme γ-secretase attenuates oncogenic potential, EMT and stemness in Triple Negative Breast Cancer (TNBC) cells and in vivo, by modulating the Autophagy/ Apoptosis balance TCS201846000 9/30/18 19:32
Dr PARSHW SINGH CLINICOPATHOLOGICAL PROFILE OF MIXED PHENOTYPE ACUTE LEUKEMIA TCS201870755 9/30/18 20:59
DIKSHA DEV YADAV Clinical and immunophenotypic charatcterisation of Early Thymic Precursor acute lymphoblastic leukemia (ETP-ALL) TCS201878443 9/30/18 23:31
RAJANI ANAND HLA-DR Positive APML In Paediatric Patient-A Rare Clinical Entity Introduction TCS201873843 10/1/18 12:04
Dr. Rahul Sharma A comparative analysis of post induction minimal residual disease over other conventional and immunophenotypic risk factors in the prognostication of adult B-Lineage Acute Lymphoblastic leukemia patients TCS201874265 10/1/18 12:26
Ms.Meetu Dahiya CLEARLLAB LS AND CLEARLLAB COMPENSATION KIT- EVALUATION OF DRY MULTICOLOR PANELS FOR LYMPHOMA & LEUKEMIA DIAGNOSIS AND MONITORING ON A FLOW CYTOMETER TCS2018COM13 10/2/2018 20:24